Patent details
EP4212152
Title:
SACUBITRIL-VALSARTAN DOSAGE REGIMEN FOR TREATING CHRONIC SYSTOLIC HEART FAILURE
Basic Information
- Publication number:
- EP4212152
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP231547571
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SACUBITRIL-VALSARTAN DOSAGE REGIMEN FOR TREATING CHRONIC SYSTOLIC HEART FAILURE
- French Title of Invention:
- SCHÉMA POSOLOGIQUE DU SACUBUTRIL-VALSARTAN POUR LE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE SYSTOLIQUE CHRONIQUE
- German Title of Invention:
- SACUBITRIL-VALSARTAN DOSIERSCHEMA ZUR BEHANDLUNG VON CHRONISCHEM SYSTOLISCHEM HERZVERSAGEN
- SPC Number:
-
Dates
- Filing date:
- 09/05/2016
- Grant date:
- 30/04/2025
- EP Publication Date:
- 19/07/2023
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 30/04/2025
- EP B1 Publication Date:
- 30/04/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 09/05/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 23/04/2025
-
-
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 02/06/2025
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- CHEN, Fabian
- Address:
- United States (US)
2
- Name:
- SHI, Victor Chengwei
- Address:
- United States (US)
3
- Name:
- RIZKALA, Adel Redmond
- Address:
- United States (US)
Priority
- Priority Number:
- 201562159703 P
- Priority Date:
- 11/05/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/225;
A61K 31/41;
A61P 9/04;
Publication
European Patent Bulletin
1
- Issue number:
- 202518
- Publication date:
- 30/04/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202523
- Publication date:
- 04/06/2025
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 01/06/2026
- Annual Fee Number:
- 11
- Annual Fee Amount:
- 148 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 25/06/2025
- Last Annual Fee Paid Number:
- 10
- Last Annual Fee Paid Amount:
- 131 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM